Paul M. Maggio
Stanford University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Paul M. Maggio.
Journal of The American College of Surgeons | 2009
Daniel J. Riskin; Thomas C. Tsai; Loren Riskin; Tina Hernandez-Boussard; Mary-Anne Purtill; Paul M. Maggio; David A. Spain; Susan I. Brundage
BACKGROUND Exsanguinating hemorrhage necessitating massive blood product transfusion is associated with high mortality rates. Recent data suggest that altering the fresh frozen plasma to packed red blood cell ratio (FFP:PRBC) results in significant mortality reductions. Our purpose was to evaluate mortality and blood product use in the context of a newly initiated massive transfusion protocol (MTP). STUDY DESIGN In July 2005, our American College of Surgeons-verified Level I trauma center implemented an MTP supporting a 1:1.5 FFP:PRBC ratio, improved communications, and enhanced systems flow to optimize rapid blood product availability. During the 4 years surrounding protocol implementation, we reviewed data on trauma patients directly admitted through the emergency department and requiring 10 or more units PRBCs during the first 24 hours. RESULTS For the 2 years before and subsequent to MTP initiation, there were 4,223 and 4,414 trauma activations, of which 40 and 37 patients, respectively, met study criteria. The FFP:PRBC ratios were identical, at 1:1.8 and 1:1.8 (p = 0.97). Despite no change in FFP:PRBC ratio, mortality decreased from 45% to 19% (p = 0.02). Other significant findings included decreased mean time to first product: cross-matched RBCs (115 to 71 minutes; p = 0.02), FFP (254 to 169 minutes; p = 0.04), and platelets (418 to 241 minutes; p = 0.01). CONCLUSIONS MTP implementation is associated with mortality reductions that have been ascribed principally to increased plasma use and decreased FFP:PRBC ratios. Our study found a significant reduction in mortality despite unchanged FFP:PRBC ratios and equivalent overall mean numbers of transfusions. Our data underscore the importance of expeditious product availability and emphasize that massive transfusion is a complex process in which product ratio and time to transfusion represent only the beginning of understanding.
Transfusion | 2014
Lawrence T. Goodnough; Paul M. Maggio; Lisa Shieh; Tina Hernandez-Boussard; Paul Khari; Neil Shah
Blood transfusion has been cited as one of the five most overutilized therapeutic procedures in the United States. We assessed the impact of clinical decision support at computerized physician order entry and education on red blood cell (RBC) transfusions and clinical patient outcomes at our institution.
Surgery | 2008
Mark R. Hemmila; Michael A. Taddonio; Saman Arbabi; Paul M. Maggio; Wendy L. Wahl
BACKGROUND Intensive insulin therapy to control blood glucose levels has reduced mortality in surgical, but not medical, intensive care unit (ICU) patients. Control of blood glucose levels has also been shown to reduce morbidity in surgical ICU patients. There is very little data for use of intensive insulin therapy in the burn patient population. We sought to evaluate our experience with intensive insulin therapy in burn-injured ICU patients with regard to mortality, morbidity, and use of hospital resources. STUDY DESIGN Burn patients admitted to our American College of Surgeons verified burn center ICU from 7/1/2004 to 6/30/2006 were studied. An intensive insulin therapy protocol was initiated for ICU patients admitted starting 7/1/2005 with a blood glucose target of 100-140 mg/dL. The 2 groups of patients studied were control (7/1/2004 to 6/30/2005) and intensive insulin therapy (7/1/2005 to 6/30/2006). All glucose values for the hospitalization were analyzed. Univariate and multivariate analyses were performed. RESULTS Overall, 152 ICU patients admitted with burn injury were available for study. No difference in mortality was evident between the control and intensive insulin therapy groups. After adjusting for patient risk, the intensive insulin therapy group was found to have a decreased rate of pneumonia, ventilator-associated pneumonia, and urinary tract infection. In patients with a maximum glucose value of greater than 140 mg/dL, the risk for an infection was significantly increased (OR 11.3, 95% CI 4-32, P-value < .001). The presence of a maximum glucose value greater than 140 mg/dL was associated with a sensitivity of 91% and specificity of 62% for an infectious complication. CONCLUSION Intensive insulin therapy for burn-injured patients admitted to the ICU was associated with a reduced incidence of pneumonia, ventilator-associated pneumonia, and urinary tract infection. Intensive insulin therapy did not result in a change in mortality or length of stay when adjusting for confounding variables. Measurement of a blood glucose level greater than 140 mg/dL should heighten the clinical suspicion for the presence of an infection in patients with burn injury.
Surgery | 2008
Mark R. Hemmila; Jill L. Jakubus; Paul M. Maggio; Wendy L. Wahl; Justin B. Dimick; Darrell A. Campbell; Paul A. Taheri
BACKGROUND Major postoperative complications are associated with a substantial increase in hospital costs. Trauma patients are known to have a higher rate of complications than the general surgery population. We used the National Surgical Quality Improvement Program (NSQIP) methodology to evaluate hospital costs, duration of stay, and payment associated with complications in trauma patients. METHODS Using NSQIP principles, patient data were collected for 512 adult patients admitted to the trauma service for > 24 hours at a Level 1 trauma center (2004-2005). Patients were placed in 1 of 3 groups: no complications (none), >or=1 minor complication (minor, eg, urinary tract infection), or >or=1 major complication (major, eg, pneumonia). Total hospital charges, costs, payment, and duration of stay associated with each complication group were determined from a cost-accounting database. Multiple regression was used to determine the costs of each type of complication after adjusting for differences in age, sex, new injury severity score, Glasgow coma scale score, maximum head abbreviated injury scale, and first emergency department systolic blood pressure. RESULTS A total of 330 (64%) patients had no complications, 53 (10%) had >or= 1 minor complication, and 129 (25%) had >or= 1 major complication. Median hospital charges increased from
Transfusion | 2014
Lawrence T. Goodnough; Lisa Shieh; Nathalie W. Cheng; Paul Khari; Paul M. Maggio
33,833 (none) to
Journal of Trauma-injury Infection and Critical Care | 2008
Wendy L. Wahl; Michael A. Taddonio; Paul M. Maggio; Saman Arbabi; Mark R. Hemmila
81,936 (minor) and
The Journal of Thoracic and Cardiovascular Surgery | 2010
Anthony D. Caffarelli; Hari R. Mallidi; Paul M. Maggio; David A. Spain; D. Craig Miller; R. Scott Mitchell
150,885 (major). The mean contribution to margin per day was similar for the no complication and minor complication groups (
Journal of Emergencies, Trauma, and Shock | 2010
Kritaya Kritayakirana; Paul M. Maggio; Susan I. Brundage; Mary-Anne Purtill; Kristan Staudenmayer; David A. Spain
994 vs
Current Opinion in Anesthesiology | 2013
Lawrence T. Goodnough; David A. Spain; Paul M. Maggio
1,115, P = .7). Despite higher costs, the patients in the major complication group generated a higher mean contribution to margin per day compared to the no complication group (
Academic Medicine | 2015
Kambria H. Evans; William Daines; Jamie Tsui; Matthew Strehlow; Paul M. Maggio; Lisa Shieh
2,168, P < .001). The attributable increase in median total hospital costs when adjusted for confounding variables was